AlphaGrep UK
ELV icon

AlphaGrep UK’s Elevance Health ELV Stock Holding History

AlphaGrep UK’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$743K Buy
1,911
+50
+3% +$20K 0.22% 88
2026
Q2 		$720K Sell
1,861
-113
-6% -$41.9K 0.21% 108
2026
Q1 		$578K Buy
1,974
+1,085
+122% +$357K 0.17% 178
2025
Q4 		$312K Buy
+889
New +$300K 0.1% 408

Other funds holding ELV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

AlphaGrep UK's ELV Position: Q3 2026 in Review

AlphaGrep UK increased its Elevance Health (ELV) stake by 2.7% in Q3 2026, buying an estimated $20K and bringing the position to 1,911 shares worth $743K. The position accounts for 0.22% of the portfolio, ranked #88.

AlphaGrep UK first reported a position in ELV in Q4 2025 and has held it in 4 quarters since. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • AlphaGrep UK held 1,911 shares of Elevance Health worth $743K as of Q3 2026.
  • AlphaGrep UK bought 50 Elevance Health shares in Q3 2026, an estimated $20K.
  • Elevance Health made up 0.22% of AlphaGrep UK's portfolio in Q3 2026, its #88 holding.
  • AlphaGrep UK first reported a position in Elevance Health in Q4 2025 and has held it in 4 quarters since.
  • 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.